| Name | protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
| Description | AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPRKAG2 encodes the γ2 regulatory subunit of AMP‐activated protein kinase (AMPK), a central energy sensor that orchestrates cellular and systemic metabolic homeostasis. Beyond its well‐established role in modulating nephrogenesis, solute transport, and angiogenesis in the kidney—where genome‐wide studies have implicated it as a susceptibility locus for reduced renal function ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]—PRKAG2 serves as a multifunctional regulator in several tissues.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the myocardium, mutations in PRKAG2 result in a distinctive cardiomyopathy marked by ventricular pre‐excitation, conduction system disease, and cardiac hypertrophy, with striking features of intracellular glycogen accumulation. Studies in affected families and in experimental models—including transgenic mice and human induced pluripotent stem cell–derived cardiomyocytes—demonstrate that these mutations disrupt the normal nucleotide (AMP/ATP) binding to the cystathionine beta‐synthase (CBS) domains of AMPK. The ensuing constitutive or “uncoupled” activation of AMPK, even in the absence of energy deficit, triggers extensive remodeling of substrate metabolism, promotes glycogen storage, perturbs ion channel and pacemaker functions (leading to bradycardia), and ultimately gives rise to conditions manifesting as Wolff–Parkinson–White syndrome and glycogen storage cardiomyopathy ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "34"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence further indicates that genetic variation in PRKAG2 extends its influence beyond the heart. Variants in PRKAG2 have been associated with altered pharmacogenomic responses—such as variability in blood pressure reduction following diuretic therapy—and may contribute to systemic metabolic and even cognitive functions. Additionally, insights into its role in regulating cellular entry pathways have been observed in studies linking PRKAG2 function to macropinocytic processes exploited by certain viruses. Together, these findings underscore the pleiotropic nature of PRKAG2, emphasizing its critical role in regulating energy metabolism, cellular homeostasis, and electrophysiological properties across diverse biological contexts."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}, {"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Anna Köttgen, Cristian Pattaro, Carsten A Böger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New loci associated with kidney function and chronic kidney disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.568"}], "href": "https://doi.org/10.1038/ng.568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20383146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20383146"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Michael Arad, Barry J Maron, Joshua M Gorham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glycogen storage diseases presenting as hypertrophic cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa033349"}], "href": "https://doi.org/10.1056/NEJMoa033349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15673802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15673802"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "M H Gollob, J J Seger, T N Gollob, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/hc5001.102111"}], "href": "https://doi.org/10.1161/hc5001.102111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11748095"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11748095"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jasvinder S Sidhu, Yadavendra S Rajawat, Tapan G Rami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.CIR.0000151291.32974.D5"}], "href": "https://doi.org/10.1161/01.CIR.0000151291.32974.D5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15611370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15611370"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ross T Murphy, Jens Mogensen, Kate McGarry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Coll Cardiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacc.2004.11.053"}], "href": "https://doi.org/10.1016/j.jacc.2004.11.053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15766830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15766830"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Barbara Burwinkel, John W Scott, Christoph Bührer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/430840"}], "href": "https://doi.org/10.1086/430840"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15877279"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15877279"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Tyrone Daniel, David Carling "}, {"type": "b", "children": [{"type": "t", "text": "Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M207093200"}], "href": "https://doi.org/10.1074/jbc.M207093200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12397075"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12397075"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ivan Luptak, Mei Shen, Huamei He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI30658"}], "href": "https://doi.org/10.1172/JCI30658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17431505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17431505"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Arash Yavari, Claire J Stocker, Sahar Ghaffari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2016.04.003"}], "href": "https://doi.org/10.1016/j.cmet.2016.04.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27133129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27133129"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ferhaan Ahmad, Michael Arad, Nicolas Musi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.105.550806"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.105.550806"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16275868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16275868"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Martha L Slattery, Jennifer S Herrick, Abbie Lundgreen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgq142"}], "href": "https://doi.org/10.1093/carcin/bgq142"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20622004"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20622004"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Michael H Gollob, Martin S Green, Anthony S L Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Opin Cardiol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00001573-200205000-00004"}], "href": "https://doi.org/10.1097/00001573-200205000-00004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12015471"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12015471"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "J Travis Hinson, Anant Chopra, Andre Lowe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2016.11.066"}], "href": "https://doi.org/10.1016/j.celrep.2016.11.066"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28009297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28009297"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Cordula M Wolf, Michael Arad, Ferhaan Ahmad, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.107.726752"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.107.726752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18158359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18158359"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ronen Ben Jehuda, Binyamin Eisen, Yuval Shemer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Heart Rhythm (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.hrthm.2017.09.024"}], "href": "https://doi.org/10.1016/j.hrthm.2017.09.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28917552"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28917552"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Robin Willows, Naveenan Navaratnam, Ana Lima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of different γ-subunit isoforms on the regulation of AMPK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BCJ20170046"}], "href": "https://doi.org/10.1042/BCJ20170046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28302767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28302767"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Pascal Laforêt, Pascale Richard, Mina Ait Said, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2005.12.004"}], "href": "https://doi.org/10.1016/j.nmd.2005.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16487706"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16487706"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sandra Marisa J Oliveira, Javed Ehtisham, Charles S Redwood, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Cardiol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0022-2828(03)00237-2"}], "href": "https://doi.org/10.1016/s0022-2828(03"}, {"type": "t", "text": "00237-2) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14519435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14519435"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Angela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Coll Cardiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacc.2020.05.029"}], "href": "https://doi.org/10.1016/j.jacc.2020.05.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32646569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32646569"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "John W Scott, Fiona A Ross, J K David Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the gamma subunit."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7601542"}], "href": "https://doi.org/10.1038/sj.emboj.7601542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17255938"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17255938"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Julien Thevenon, Gabriel Laurent, Flavie Ader, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Europace (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/europace/euw067"}], "href": "https://doi.org/10.1093/europace/euw067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28431061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28431061"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Pauli Pöyhönen, Anita Hiippala, Laura Ollila, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cardiovasc Magn Reson (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12968-015-0192-3"}], "href": "https://doi.org/10.1186/s12968-015-0192-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26496977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26496977"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Andrew S Kondratowicz, Catherine L Hunt, Robert A Davey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.01634-12"}], "href": "https://doi.org/10.1128/JVI.01634-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23115293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23115293"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Arash Yavari, Mohamed Bellahcene, Annalisa Bucchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mammalian γ2 AMPK regulates intrinsic heart rate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-01342-5"}], "href": "https://doi.org/10.1038/s41467-017-01342-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29097735"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29097735"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Carl J Vaughan, Yolanda Hom, Daniel A Okin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cardiovasc Electrophysiol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1540-8167.2003.02394.x"}], "href": "https://doi.org/10.1046/j.1540-8167.2003.02394.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12716108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12716108"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Karalyn D Folmes, Anita Y M Chan, Debby P Y Koonen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Cardiovasc Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCGENETICS.108.834564"}], "href": "https://doi.org/10.1161/CIRCGENETICS.108.834564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20031621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20031621"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Sanjay K Banerjee, Kenneth R McGaffin, Xueyin N Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2009.12.001"}], "href": "https://doi.org/10.1016/j.bbadis.2009.12.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20005292"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20005292"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Hanno L Tan, Allard C van der Wal, Maria E Campian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Arrhythm Electrophysiol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCEP.108.782862"}], "href": "https://doi.org/10.1161/CIRCEP.108.782862"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19808419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19808419"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Bi-li Zhang, Rong-liang Xu, Jing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cardiol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jjcc.2013.04.010"}], "href": "https://doi.org/10.1016/j.jjcc.2013.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23778007"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23778007"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Eosu Kim, Sung Hee Lee, Kang Soo Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AMPK γ2 subunit gene PRKAG2 polymorphism associated with cognitive impairment as well as diabetes in old age."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychoneuroendocrinology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.psyneuen.2011.07.005"}], "href": "https://doi.org/10.1016/j.psyneuen.2011.07.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21813245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21813245"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Dan Hu, Dong Hu, Liwen Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2020.102723"}], "href": "https://doi.org/10.1016/j.ebiom.2020.102723"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32259713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32259713"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Yongkun Zhan, Xiaolei Sun, Bin Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Cardiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yjmcc.2018.02.007"}], "href": "https://doi.org/10.1016/j.yjmcc.2018.02.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29452156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29452156"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Mohamed H Shahin, Yan Gong, Caitrin W McDonough, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/HYPERTENSIONAHA.116.07328"}], "href": "https://doi.org/10.1161/HYPERTENSIONAHA.116.07328"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27381900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27381900"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Li-Ping Zhang, Bin Hui, Bing-Ren Gao "}, {"type": "b", "children": [{"type": "t", "text": "High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Electrocardiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jelectrocard.2010.02.009"}], "href": "https://doi.org/10.1016/j.jelectrocard.2010.02.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20381067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20381067"}]}]}]}
|
| Synonyms | WPWS, CMH6, AAKG, AAKG2, H91620P |
| Proteins | AAKG2_HUMAN |
| NCBI Gene ID | 51422 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PRKAG2 has 8,348 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 134 datasets.
Click the + buttons to view associations for PRKAG2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRKAG2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRKAG2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRKAG2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving PRKAG2 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PRKAG2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRKAG2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRKAG2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PRKAG2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRKAG2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PRKAG2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PRKAG2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PRKAG2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRKAG2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PRKAG2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PRKAG2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with PRKAG2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with PRKAG2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing PRKAG2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRKAG2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PRKAG2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PRKAG2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing PRKAG2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing PRKAG2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PRKAG2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PRKAG2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRKAG2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PRKAG2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PRKAG2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PRKAG2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PRKAG2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PRKAG2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PRKAG2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving PRKAG2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving PRKAG2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with PRKAG2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PRKAG2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PRKAG2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PRKAG2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PRKAG2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PRKAG2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PRKAG2 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRKAG2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRKAG2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PRKAG2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PRKAG2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PRKAG2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PRKAG2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PRKAG2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PRKAG2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PRKAG2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PRKAG2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRKAG2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PRKAG2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRKAG2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PRKAG2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PRKAG2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PRKAG2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PRKAG2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PRKAG2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PRKAG2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PRKAG2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PRKAG2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PRKAG2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PRKAG2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PRKAG2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PRKAG2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PRKAG2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with PRKAG2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PRKAG2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PRKAG2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PRKAG2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRKAG2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PRKAG2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PRKAG2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PRKAG2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with PRKAG2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PRKAG2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with PRKAG2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PRKAG2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PRKAG2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PRKAG2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PRKAG2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PRKAG2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PRKAG2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving PRKAG2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving PRKAG2 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate PRKAG2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRKAG2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRKAG2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PRKAG2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PRKAG2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PRKAG2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PRKAG2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRKAG2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PRKAG2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PRKAG2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PRKAG2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PRKAG2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing PRKAG2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with PRKAG2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PRKAG2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRKAG2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PRKAG2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PRKAG2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PRKAG2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving PRKAG2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PRKAG2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PRKAG2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRKAG2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRKAG2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PRKAG2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PRKAG2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PRKAG2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of PRKAG2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PRKAG2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PRKAG2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PRKAG2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PRKAG2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PRKAG2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PRKAG2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRKAG2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PRKAG2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRKAG2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PRKAG2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PRKAG2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PRKAG2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PRKAG2 protein from the WikiPathways Pathways 2024 dataset. | |